兔抗KLK13多克隆抗體

Background:

Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. Expression of this gene is regulated by steroid hormones and may be useful as a marker for breast cancer. An additional transcript variant has been identified, but its full length sequence has not been determined.

Applications:

ELISA, IHC

Name of antibody:

KLK13

Immunogen:

Fusion protein of human KLK13

Full name:

kallikrein-related peptidase 13

Synonyms：

KLKL4; KLK-L4

SwissProt:

Q9UKR3

ELISA Recommended dilution:

1000-2000

IHC positive control:

Human brain and human thyroid cancer

IHC Recommend dilution:

25-100